Deborah A. Paul

Design, Activity, and 2.8 Å Crystal Structure of a <i>C</i> ₂ Symmetric Inhibitor Complexed to HIV-1 Protease

John W. Erickson, David J. Neidhart, John H. VanDrie et al. · Science · 1990 · 528 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +17

Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.

J. M. A. Lange, Deborah A. Paul, Han G. Huisman et al. · BMJ · 1986 · 342 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Long-Term Evaluation of HIV Antigen and Antibodies to p24 and gp41 in Patients with Hemophilia

J P Allain, Y. Laurian, Deborah A. Paul et al. · New England Journal of Medicine · 1987 · 246 citations

Life Sciences, Immunology, Infectious Diseases +14

Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles

A H Kaplan, Jerome A. Zack, Molly A. Knigge et al. · Journal of Virology · 1993 · 231 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Structure-based, C2 symmetric inhibitors of HIV protease

Dale J. Kempf, Daniel W. Norbeck, LynnMarie Codacovi et al. · Journal of Medicinal Chemistry · 1990 · 211 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13